The Two Stage Model of Preeclampsia: Variations on the Theme
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
The Two Stage Model of preeclampsia proposes that a poorly perfused placenta (Stage 1) produces factor(s) leading to the clinical manifestations of preeclampsia (Stage2). Stage 1 is not sufficient to cause the maternal syndrome but interacts with maternal constitutional factors (genetic, behavioral or environmental) to result in Stage 2. Recent information indicates the necessity for modifications of this model. It is apparent that changes relevant to preeclampsia and other implantation disorders can be detected in the first trimester, long before the failed vascular remodeling necessary to reduce placental perfusion. In addition, although the factor(s) released from the placenta has usually been considered a toxin, we suggest that what is released may also be an appropriate signal from the fetal/placental unit to overcome reduced nutrient availability that cannot by tolerated by some women who develop preeclampsia. Further, it is evident that linkage is not likely to be by one factor but several, different for different women. Also although the initial model limited the role of maternal constitutional factors to the genesis of Stage 2, this does not appear to be the case. It is evident that the factors increasing risk for preeclampsia are also associated with abnormal implantation. These several modifications have important implications. An earlier origin for Stage 1, which appears to be recognizable by altered concentrations of placental products, could allow earlier intervention. The possibility of a fetal placental factor increasing nutrient availability could provide novel therapeutic options. Different linkages and preeclampsia subtypes could direct specific preventive treatments for different women while the role of maternal constitutional factors to affect placentation provides targets for prepregnancy therapy. The modified Two Stage Model provides a useful guide towards investigating pathophysiology and guiding therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Latest Advances in Understanding Preeclampsia
Redman, C. W., & Sargent, I. L. (2005) · Science · doi:10.1126/science.1111726 · Cited by 2,607
KHONG, T. Y., DE WOLF, F., ROBERTSON, W. B., & BROSENS, I. (1986) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1986.tb07830.x · Cited by 1,591
Irgens, H. U., Roberts, J. M., Reisæter, L., Irgens, L. M., & Lie, R. T. (2001) · BMJ · doi:10.1136/bmj.323.7323.1213 · Cited by 1,040 · cited 1×
“Furthermore, preeclampsia of early onset is much more likely to be associated with later life cardiovascular disease suggesting extensive involvement of the maternal constitution [39].”
BackgroundSelf-citationPlacental Origins of Preeclampsia: Challenging the Current Hypothesis
Huppertz, B. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.107607 · Cited by 893
Sacks, G. P., Studena, K., Sargent, I. L., & Redman, C. W. G. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70254-6 · Cited by 824
The journal of maternal-fetal & neonatal medicine
Societies, O. P. (2002) · Cited by 675
Ness, R. B., & Roberts, J. M. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70056-x · Cited by 569
Self-citationSavvidou, M. D., Hingorani, A. D., Tsikas, D., Frölich, J. C., Vallance, P., & Nicolaides, K. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13177-7 · Cited by 514
Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre‐eclampsia
Plasencia, W., Maiz, N., Bonino, S., Kaihura, C., & Nicolaides, K. H. (2007) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.5157 · Cited by 425
Goswami, D., Tannetta, D. S., Magee, L. A., Fuchisawa, A., Redman, C. W. G., Sargent, I. L., & von Dadelszen, P. (2006) · Placenta · doi:10.1016/j.placenta.2004.11.007 · Cited by 402
Cited by
Steegers, E. A., von Dadelszen, P., Duvekot, J. J., & Pijnenborg, R. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60279-6 · Cited by 2,850
The “Great Obstetrical Syndromes” are associated with disorders of deep placentation
Brosens, I., Pijnenborg, R., Vercruysse, L., & Romero, R. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.08.009 · Cited by 1,568
Preeclampsia and Future Cardiovascular Health: A Systematic Review and Meta-Analysis
Wu, P., Haththotuwa, R., Kwok, C. S., Babu, A., Kotronias, R. A., Rushton, C., Zaman, A., Fryer, A. A., Kadam, U., Chew-Graham, C. A., et al. (2017) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.116.003497 · Cited by 1,147
Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy
Hutcheon, J. A., Lisonkova, S., & Joseph, K. S. (2011) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2011.01.006 · Cited by 1,045
Antiplatelet agents for preventing pre-eclampsia and its complications
Duley, L., Henderson-Smart, D. J., Meher, S., & King, J. F. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004659.pub2 · Cited by 1,016
Lisonkova, S., & Joseph, K. S. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.08.019 · Cited by 924
Preeclampsia: Updates in Pathogenesis, Definitions, and Guidelines
Phipps, E., Prasanna, D., Brima, W., & Jim, B. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.12081115 · Cited by 622
Placental Stress and Pre-eclampsia: A Revised View
Redman, C. W. G., & Sargent, I. L. (2009) · Placenta · doi:10.1016/j.placenta.2008.11.021 · Cited by 590
Roberts, J. M., & Escudero, C. (2012) · Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health · doi:10.1016/j.preghy.2012.01.001 · Cited by 426
Self-citationDrugs for treatment of very high blood pressure during pregnancy
Duley, L., Meher, S., & Jones, L. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001449.pub3 · Cited by 423
Ji, L., Brkić, J., Liu, M., Fu, G., Peng, C., & Wang, Y.-L. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.12.008 · Cited by 387
Melatonin and stable circadian rhythms optimize maternal, placental and fetal physiology
Reiter, R. J., Tan, D. X., Korkmaz, A., & Rosales-Corral, S. A. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmt054 · Cited by 371
Antiplatelet agents for preventing pre-eclampsia and its complications
Duley, L., Meher, S., Hunter, K. E., Seidler, A. L., & Askie, L. M. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004659.pub3 · Cited by 366
Pregnancy-Induced hypertension
Kintiraki, E., Papakatsika, S., Kotronis, G., Goulis, D. G., & Kotsis, V. (2015) · Hormones · doi:10.14310/horm.2002.1582 · Cited by 330
Maternal Morbidity Associated With Early-Onset and Late-Onset Preeclampsia
Lisonkova, S., Sabr, Y., Mayer, C., Young, C., Skoll, A., & Joseph, K. S. (2014) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000472 · Cited by 307
Preeclampsia beyond pregnancy: long-term consequences for mother and child
Turbeville, H. R., & Sasser, J. M. (2020) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00071.2020 · Cited by 306
Potential markers of preeclampsia – a review
Grill, S., Rusterholz, C., Zanetti-Dällenbach, R., Tercanli, S., Holzgreve, W., Hahn, S., & Lapaire, O. (2009) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-7-70 · Cited by 293
Preeclampsia, Placental Insufficiency, and Autism Spectrum Disorder or Developmental Delay
Walker, C. K., Krakowiak, P., Baker, A., Hansen, R. L., Ozonoff, S., & Hertz-Picciotto, I. (2015) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2014.2645 · Cited by 292
Preeclampsia: multiple approaches for a multifactorial disease
Pennington, K. A., Schlitt, J. M., Jackson, D. L., Schulz, L. C., & Schust, D. J. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.008516 · Cited by 288
Tomimatsu, T., Mimura, K., Matsuzaki, S., Endo, M., Kumasawa, K., & Kimura, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174246 · Cited by 277
Long-Term Cardiovascular Risks Associated With Adverse Pregnancy Outcomes
Lane-Cordova, A. D., Khan, S. S., Grobman, W. A., Greenland, P., & Shah, S. J. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.12.092 · Cited by 269
Chang, K.-J., Seow, K.-M., & Chen, K.-H. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20042994 · Cited by 266
Westbrook, R. H., Dusheiko, G., & Williamson, C. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.030 · Cited by 264
If we know so much about preeclampsia, why haven’t we cured the disease?
Roberts, J. M., & Bell, M. J. (2013) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2013.05.003 · Cited by 189
Self-citationMasoudian, P., Nasr, A., de Nanassy, J., Fung-Kee-Fung, K., Bainbridge, S. A., & El Demellawy, D. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.11.020 · Cited by 157
Brosens, I., Pijnenborg, R., & Benagiano, G. (2013) · Placenta · doi:10.1016/j.placenta.2012.11.017 · Cited by 135
Schoenaker, D. A., Soedamah-Muthu, S. S., Callaway, L. K., & Mishra, G. D. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.102475 · Cited by 124
Environmental contaminants and preeclampsia: a systematic literature review
Rosen, E. M., Muñoz, M. I., McElrath, T., Cantonwine, D. E., & Ferguson, K. K. (2018) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937404.2018.1554515 · Cited by 74
“Evidence for this heterogeneity exists throughout the literature (Eskenazi et al. 1993; Powers et al. 2012; Roberts and Hubel 2009; Roberts and Von Versen-Hoeynck 2007), but Redman and Staff (2015) proposed an alternative placental-derived explanation for the “maternal preeclampsia” subtype, which…”
BackgroundBommarito, P. A., Ferguson, K. K., Meeker, J. D., McElrath, T. F., & Cantonwine, D. E. (2021) · Environmental Health Perspectives · doi:10.1289/ehp9091 · Cited by 70
Zhong, W., Xie, Y., Abdallah, M., Awonuga, A. O., Slater, J. A., Sipahi, L., Puscheck, E. E., & Rappolee, D. A. (2010) · Reproduction · doi:10.1530/rep-10-0268 · Cited by 48
“Two recent reviews suggested that preeclampsia and intrauterine growth retardation begin with deficiencies in decision making in peri-implantation and early first trimester placental stem cells (Huppertz 2008, Roberts & Hubel 2009).”
BackgroundSzalai, G., Romero, R., Chaiworapongsa, T., Xu, Y., Wang, B., Ahn, H., Xu, Z., Chiang, P. J., Sundell, B., Wang, R., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119547 · Cited by 46
Risk for preeclampsia following exposure to PM2.5 during pregnancy
Daniel, S., Kloog, I., Factor-Litvak, P., Levy, A., Lunenfeld, E., & Kioumourtzoglou, M.-A. (2021) · Environment International · doi:10.1016/j.envint.2021.106636 · Cited by 26
Placental histopathology and pregnancy outcomes in “early” vs. “late” placental abruption
Gonen, N., Levy, M., Kovo, M., Schreiber, L., Noy, L. K., Volpert, E., Bar, J., & Weiner, E. (2021) · Reproductive Sciences · doi:10.1007/s43032-020-00287-3 · Cited by 22
Placental Drug Delivery to Treat Pre‐Eclampsia and Fetal Growth Restriction
Deepak, V., El‐Balawi, L., & Harris, L. K. (2024) · Small · doi:10.1002/smll.202311165 · Cited by 16
Metadata
- Authors
- Roberts, J. M., & Hubel, C. A.
- Venue
- Placenta
- Publisher
- Elsevier BV
- Published
- 2009-03
- Volume
- 30
- Pages
- 32-37
- ISSN
- 0143-4004 (ISSN-L)
- OpenAlex
- W1976868429
- Cited by
- 922
- References
- 42
- FWCI
- 29.57
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.